ITGAM and neoplasm: Granulocytic myeloid-derived suppressor cells (Gr-MDSCs) (CD11b+Ly6G+Ly6Clow) decreased by 2.5-fold in N6L-treated tumours compared to control tumours (Figure 2C), and the monocytic myeloid-derived suppressor cell (M-MDSCs) population (CD11b+Ly6GlowLy6C+) slightly increased (Figure 2C).